Bharat Biotech to produce 700 million COVAXIN doses per year
Image Credit: shortpedia
To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, COVAXIN, to 700 million doses per annum, the vaccine maker said on Tuesday. Manufacturing scale-up has been carried out in a stepwise manner across multiple facilities at Hyderabad and Bengaluru, the company said in a statement.